 |
인쇄하기
취소
|
Kim Won-bae renamed as head of Dong-A
Kim Won-bae, incumbent Dong-A Pharmaceutical Co., was renamed last Friday as its president in the annual shareholders' meeting.
Kim, who served as CEO of Dong-A for almost ten years since March 2003, will serve his fourth term presidency.
Industry watchers said Kim is likely to be in charge of major business strategies of Dong-A such as securing new growth engines, as he was highly credit...
Kim, who served as CEO of Dong-A for almost ten years since March 2003, will serve his fourth term presidency.
Industry watchers said Kim is likely to be in charge of major business strategies of Dong-A such as securing new growth engines, as he was highly credit...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.